IIPLA News
Thursday, May 14, 2026

UK Intellectual Property Framework Maintains Continuity Through Brexit Transition Period

Withdrawal Agreement ensures uninterrupted IP rights protection and conversion of EU trademarks and designs into UK equivalents by January 2021

IIPLA News Deskanonymous access0 articles left this week
UK Intellectual Property Framework Maintains Continuity Through Brexit Transition Period
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

The UK government confirms that during the Brexit transition period from February 1 to December 31, 2020, EU intellectual property laws will continue to apply in the UK without disruption. The Intellectual Property Office (IPO) will convert nearly 1.4 million EU trademarks and 700,000 EU designs into comparable UK rig…
Share This Article
Ready-to-post copy includes the article link.

UK Intellectual Property Framework Maintains Continuity Through Brexit Transition Period The UK government confirms that during the Brexit transition period from February 1 to December 31, 2020, EU intellectual property laws will continue to apply in the UK without disruption. The Intellectual Property Offi... Read the full IIPLA article: https://iipla.org/news/uk-intellectual-property-framework-maintains-continuity-through-brexit-transition-period

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

JOOLA Settles Patent Dispute with Paddletek and ProXR, Establishes Royalty Agreement

JOOLA has reached a settlement with Paddletek Group and ProXR Pickleball concerning patent infringement claims related to JOOLA's propulsion core technology. The agreement includes royalty payments and a phased discontinuation of affected products, marking a cooperative resolution five weeks after the initial lawsuit.…

Thursday, May 14, 2026
PatentsEurope

Philips Leads European Patent Office Medtech Filings in 2024 with 594 Applications

In 2024, Royal Philips emerged as the leading medical technology patent applicant at the European Patent Office, filing 594 Medtech patents. This milestone highlights Philips’ sustained investment in R&D, focusing on AI and informatics to enhance patient care and operational efficiency in hospitals and homes worldwide.

Thursday, May 14, 2026